BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7855765)

  • 1. [Drug-induced Parkinson syndrome: 10 years of drug vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Therapie; 1994; 49(5):459-60. PubMed ID: 7855765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of drug induced parkinsonism in psychotic patients].
    Giroud-Benítez JL; López-Suárez RM; Méndez-Chávez A; Vistorte-Pupo A; González-Torres R; López-Jaén I; Pradere-Pensado JC; Enriquez Lescano Gort L; Paz-Sendin L
    Rev Neurol; 2001 Dec 1-15; 33(11):1095-7. PubMed ID: 11785039
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug-induced parkinsonism].
    Levin OS; Shindriaeva NN; Anikina MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):76-81. PubMed ID: 23096050
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug induced parkinsonism: a common cause of parkinsonism in older people.
    Thanvi B; Treadwell S
    Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
    Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
    Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
    Negrotti A; Calzetti S; Sasso E
    Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parkinsonism following addition of fluoxetine to the treatment with neuroleptics or carbamazepine].
    Touw DJ; Gernaat HB; van der Woude J
    Ned Tijdschr Geneeskd; 1992 Feb; 136(7):332-4. PubMed ID: 1347157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parkinson disease or drug-induced parkinsonism?].
    Martí-Massó JF
    Rev Neurol; 1995; 23(123):983-5. PubMed ID: 8556610
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetry of abnormal involuntary movements: a prevalence study.
    Myslobodsky MS; Holden T; Sandler R
    Biol Psychiatry; 1984 Apr; 19(4):623-8. PubMed ID: 6145450
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parkinson syndrome from diltiazem].
    Remblier C; Kassir A; Richard D; Pérault MC; Guibert S
    Therapie; 2001; 56(1):57-9. PubMed ID: 11322019
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy and diagnosis of patients with drug-induced parkinsonism].
    Yamamoto T
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1467-71. PubMed ID: 13677896
    [No Abstract]   [Full Text] [Related]  

  • 14. Does smoking reduce the risk of neuroleptic parkinsonoids?
    Wagner B; Wolf GK; Ulmar G
    Pharmacopsychiatry; 1988 Nov; 21(6):302-3. PubMed ID: 2907632
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of antihypertensives and the risk of Parkinson disease.
    Becker C; Jick SS; Meier CR
    Neurology; 2008 Apr; 70(16 Pt 2):1438-44. PubMed ID: 18256367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parkinson syndrome, a possible adverse effect of calcium inhibitors].
    Malaterre HR; Lauribe P; Paganelli F; Ramond B; Lévy S
    Arch Mal Coeur Vaiss; 1992 Sep; 85(9):1335-7. PubMed ID: 1290396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Various encephalopathies caused by drugs].
    Uldry PA; Regli F; Naegeli C
    Schweiz Rundsch Med Prax; 1989 Jun; 78(23):658-62. PubMed ID: 2568672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comment on the contribution by R. Hefner and P.-A. Fischer. Increase in Parkinson symptoms in treatment with calcium antagonists].
    Philipps GR
    Nervenarzt; 1989 Sep; 60(9):587. PubMed ID: 2812165
    [No Abstract]   [Full Text] [Related]  

  • 19. [Increase in Parkinson symptoms caused by calcium antagonists].
    Hefner R; Fischer PA
    Nervenarzt; 1989 Mar; 60(3):187-8. PubMed ID: 2654677
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale].
    Torrini M; Masini E; Ledda F; Mannaioni PF
    Clin Ter; 1981 Jun; 97(6):561-85. PubMed ID: 7023804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.